Introduction

“content”: “

Introduction

CAN/CSA C22.2 No. 80601-2-70-17 is the Canadian national adoption of the international standard IEC 80601-2-70:2015, which specifies particular requirements for the basic safety and essential performance of sleep apnoea breathing therapy equipment. These devices—commonly known as CPAP, APAP, or BiPAP machines—are used to treat sleep-disordered breathing in both home care and professional healthcare environments. As part of the CSA C22.2 series for medical electrical equipment, this standard establishes critical safety margins and performance criteria to protect patients, operators, and the environment.

Scope and Application

The standard applies to sleep apnoea breathing therapy equipment intended to deliver a therapeutic breathing gas through a patient interface, including devices with integrated humidifiers or external monitoring accessories. It covers equipment rated for use in residential and institutional settings. Specifically excluded are negative-pressure ventilators, high-frequency jet ventilators, and oxygen concentrators unless they serve as integral components of a sleep apnoea therapy system.

Tip: Manufacturers should verify that their device’s intended use aligns precisely with the definition of “sleep apnoea breathing therapy equipment” in Clause 201.3.201 of the standard to avoid misinterpretation of scope exclusions.

Key Technical Requirements

CAN/CSA C22.2 No. 80601-2-70-17 builds upon the general safety framework of IEC 60601-1 and incorporates specific provisions for sleep apnoea therapy. The main technical areas covered include:

Essential Performance

Essential performance is defined in terms of delivered pressure accuracy, flow rate control, and alarm functionality. The standard mandates that the device maintain a mean pressure within ±0.2 hPa (0.2 cmH2O) of the set value under normal operating conditions. Flow measurements must be accurate to within ±5% of the reading or ±0.5 L/min, whichever is greater.

Safety Requirements

Electrical safety follows IEC 60601-1 with Canadian deviations for supply voltage (120 V / 60 Hz) and plug configurations. Mechanical requirements address risk of patient injury from moving parts, overheating of heaters, and biocompatibility of patient-contact materials. The standard also requires that alarms for circuit disconnection, power failure, and excessive pressure meet the classification and priority levels outlined in IEC 60601-1-8.

Parameter Requirement Test Condition
Delivered pressure accuracy ±0.2 hPa (0.2 cmH2O) or ±2% of reading (whichever is greater) At set pressure between 4 hPa and 30 hPa
Flow measurement accuracy ±5% of reading or ±0.5 L/min Flow range 0–180 L/min
Alarm condition response time ≤ 10 s for high-priority alarms Simulated disconnection or leak
Maximum sound pressure level ≤ 30 dBA (at 1 m) for home-use devices Acoustic test per ISO 80601-2-70
Overpressure protection Automatic shut-off or pressure relief at ≤ 40 hPa Blocked patient circuit test
Warning: Devices that fail the accuracy or alarm response requirements can pose a direct risk to patient safety. A pressure deviation of more than ±0.5 hPa can significantly alter therapy effectiveness and lead to suboptimal treatment outcomes.

Implementation and Testing

To demonstrate compliance, manufacturers must follow a comprehensive verification and validation process. Risk management per ISO 14971 is required and must specifically address hazards related to therapy interruption, incorrect pressure delivery, and fire risk from electrical or thermal sources. Testing includes:

  • Electrical safety tests (dielectric strength, leakage current, grounding) per CSA C22.2 No. 60601-1.
  • Functional performance tests under simulated breathing loads (e.g., ISO 17510:2015 test lung).
  • Environmental conditioning (temperature, humidity, altitude) to ensure stability across home environments.
  • Usability evaluation per IEC 60601-1-6 to confirm that alarms are correctly understood and responded to.
Compliance Note: Certification bodies such as CSA Group and UL Solutions offer testing and certification packages that align with the latest edition of this standard. Early engagement with a recognized certification body can streamline the approval process for Health Canada licensing.

Compliance and Certification Notes

CAN/CSA C22.2 No. 80601-2-70-17 is recognized as a mandatory standard for medical device licensing in Canada. Manufacturers must ensure their device meets both the Canadian and any applicable provincial requirements. It is important to note that the standard may be updated: – For devices sold internationally, harmonization with the IEC edition helps reduce redundant testing, but the Canadian standard must be used specifically for Health Canada regulatory filings.

Common Non-Compliance Issues: Frequent findings during certification include inadequate alarm classification (e.g., incorrectly prioritizing a power failure alarm as medium instead of high), insufficient documentation of risk controls, and failure to test with a compliant patient circuit (including tubing with specified resistance). Pay special attention to Clause 201.12.4.8 on overpressure protection.

Compliance with CAN/CSA C22.2 No. 80601-2-70-17 is a cornerstone for bringing safe and effective sleep apnoea therapy devices to the Canadian market. By integrating the standard’s technical requirements early in the design process and working closely with accredited testing laboratories, manufacturers can ensure a smooth certification pathway and deliver high-quality therapy solutions to patients.


Published 2026 – for the latest updates, refer to the CSA Group website or your certifying body.

Frequently Asked Questions

Q: What is the main difference between CAN/CSA C22.2 No. 80601-2-70-17 and IEC 80601-2-70?
A: The Canadian standard is technically identical to the IEC edition but includes specific deviations for supply voltage (120 V/60 Hz), bilingual labeling in English and French, and additional humidifier safety tests relevant to domestic plumbing conditions. These deviations are detailed in the foreword and Annex ZA of the CSA document.
Q: Does this standard apply to CPAP machines used solely at home?
A: Yes. The standard explicitly covers sleep apnoea breathing therapy equipment intended for both professional healthcare and home care environments. Home-use devices must still meet the full range of safety and performance requirements, though some testing (e.g., acoustic noise limits) may differ slightly from institutional-device criteria.
Q: Is it mandatory to use CAN/CSA C22.2 No. 80601-2-70-17 for Health Canada medical device licensing?
A: Yes. Health Canada requires that medical devices demonstrate compliance with recognized standards. For sleep apnoea breathing therapy equipment, CAN/CSA C22.2 No. 80601-2-70-17 is the applicable standard and must be referenced in a manufacturer’s declaration of conformity or provided as part of the certification dossier.
Q: How often is the standard revised, and where can I find updates?
A: Standards are typically reviewed on a five‑year cycle. The current edition is 2017. Manufacturers should monitor the CSA Group online store and the Standards Council of Canada for announcements regarding amendments or new editions. Participation in the relevant CSA technical committee can also provide early visibility into changes.

📥 Standard Documents Download

🔒
Please wait 10 seconds, the download links will appear after the ad loads

Leave a Reply

Your email address will not be published. Required fields are marked *